Exposure, Relaxation, and Rescripting Therapy for Trauma Nightmares
(ERRT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores Exposure, Relaxation, and Rescripting Therapy (ERRT), which reduces trauma-related nightmares and improves sleep quality. The study aims to understand how different parts of the therapy contribute to its effectiveness by testing various approaches, such as focusing on sleep or enhanced exposure techniques. It targets individuals who have experienced a traumatic event and have nightmares about once a week. Participants will attend 5 to 6 therapy sessions, each lasting about 90 minutes, to evaluate the effectiveness of different therapy techniques. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance therapeutic approaches for trauma-related nightmares.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that Exposure, Relaxation, and Rescripting Therapy is safe for treating trauma-related nightmares?
Research shows that Exposure, Relaxation, and Rescripting Therapy (ERRT) is generally safe for individuals with trauma-related nightmares. Studies have found that ERRT reduces the frequency and intensity of these nightmares, improves overall sleep quality, and lessens symptoms of PTSD and depression. Importantly, these studies reported no serious side effects, indicating that the therapy is well-tolerated.
Participants in these studies often experienced lower heart rates during nightmare imagery, suggesting a calming effect from the therapy. In one study, 15.2% of veterans reported no longer having nightmares, and many others experienced improved sleep after completing ERRT. While researchers continue to explore the therapy's mechanisms, the evidence supports its safety and effectiveness.12345Why are researchers excited about this trial?
Researchers are excited about the Exposure, Relaxation, and Rescripting Therapy (ERRT) for trauma nightmares because it offers a fresh take on handling distressing dreams. Unlike traditional therapies such as medication or cognitive-behavioral therapy that generally focus on symptom management, ERRT directly addresses the nightmare content and emotional responses. The therapy's unique approach includes specific techniques like "rescripting," where the nightmare is transformed into a less distressing story, and enhanced sleep strategies to improve overall sleep quality. By combining these elements, ERRT aims to provide more comprehensive and lasting relief for individuals suffering from trauma-induced nightmares.
What evidence suggests that this trial's treatments could be effective for trauma-related nightmares?
Research shows that Exposure, Relaxation, and Rescripting Therapy (ERRT) effectively treats trauma-related nightmares. Studies have found that ERRT significantly reduces the frequency and intensity of these nightmares. It also improves overall sleep quality for both civilians and veterans. Participants in this trial will be assigned to different ERRT-based treatment arms, such as ERRT-Sleep, ERRT-Enhanced Exposure, or ERRT-Rescription, each focusing on specific techniques. After ERRT, participants often experience a decrease in symptoms of PTSD (post-traumatic stress disorder) and depression. The treatment includes learning, relaxation exercises, and altering the narrative of nightmares to address sleep problems. This method is well-supported as a recommended treatment, highlighting its potential benefits.24678
Who Is on the Research Team?
Joanne L Davis, PhD
Principal Investigator
University of Tulsa
Are You a Good Fit for This Trial?
This trial is for adults who have experienced a traumatic event and suffer from frequent trauma-related nightmares, at least once weekly over the past month. Participants must be able to read and speak English. It's not suitable for individuals under 18, those with active suicidal thoughts, unmedicated bipolar disorder, recent substance abuse issues, psychosis, recent self-harm behaviors or intellectual disabilities.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 5 to 6 weekly sessions of Exposure, Relaxation, and Rescripting Therapy (ERRT) for chronic post-trauma nightmares
Follow-up
Participants are monitored for changes in nightmare frequency and other symptoms after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Exposure, Relaxation, and Rescripting Therapy
Trial Overview
The study tests Exposure, Relaxation, and Rescripting Therapy (ERRT), a psychological treatment aimed at reducing the frequency and severity of post-trauma nightmares and improving sleep quality. The trial seeks to understand how different components of ERRT contribute to its effectiveness through weekly sessions lasting about 90 minutes each.
How Is the Trial Designed?
5
Treatment groups
Active Control
Exposure, Relaxation, and Rescripting Therapy, 5 sessions, with enhanced sleep techniques
Exposure, Relaxation, and Rescripting Therapy, 5 sessions, with enhanced exposure techniques
Exposure, Relaxation, and Rescripting Therapy, 5 sessions, with rescription but no exposure
Consensus Protocol, 6 sessions, includes components of ERRT and other nightmare protocols.
Exposure, Relaxation, and Rescripting Therapy protocol, 5 sessions, focused on sleep and relaxation
Exposure, Relaxation, and Rescripting Therapy is already approved in United States, European Union for the following indications:
- Trauma-related nightmares
- Sleep disturbances
- PTSD symptoms
- Depression symptoms
- Trauma-related nightmares
- Sleep disturbances
- PTSD symptoms
- Depression symptoms
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Tulsa
Lead Sponsor
Published Research Related to This Trial
Citations
Exposure, relaxation, and rescripting therapy could treat ...
The treatment components of ERRT involve psychoeducation about trauma, nightmares, and sleep, sleep habit modification, relaxation training, and nightmare ...
Physiological Predictors of Response to Exposure ...
This randomized clinical trial replicated a study of exposure, relaxation, and rescripting therapy(ERRT) and extended prior research.
3.
clinicaltrials.gov
clinicaltrials.gov/study/NCT02242110?term=AREA%5BBasicSearch%5D(Bipolar%20Disorder)&rank=1NCT02242110 | Brief Treatment for Trauma Nightmares in ...
This pilot study will examine the efficacy of Exposure, Relaxation, & Rescripting Therapy (ERRT) on chronic nightmares in trauma-exposed adults diagnosed ...
Empirical Research – ERRT - Sites at TU
Two case studies are presented which examine the use of Exposure, Relaxation, and Rescripting Therapy (ERRT) for chronic trauma-related nightmares, within a ...
Imagery rescripting and exposure group treatment of ...
This study details results of an open trial of a group psychological treatment for Veterans with posttraumatic stress disorder (PTSD) and chronic posttraumatic ...
Management of nightmares in patients with posttraumatic ...
Randomized controlled trial to dismantle exposure, relaxation, and rescripting therapy (ERRT) for trauma-related nightmares. Psychol Trauma. 2018;10(1):67 ...
Physiological Predictors of Response to Exposure, ...
Treatment-related decreases in heart rate to nightmare imagery were correlated with improve- ments in sleep quality and quantity; treatment-related decreas- es ...
Full article: An Expert Consensus Statement for ...
Randomized controlled trial to dismantle exposure, relaxation, and rescripting therapy (ERRT) for trauma-related nightmares. Psychological ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.